Pfizer will stop the development of its twice-daily weight loss pill due to adverse side effects.
Share:
More In Business
OpenAI shows off Stargate AI data center in Texas and plans five more
OpenAI CEO Sam Altman has announced that the Stargate AI data center in Texas will be joined by five more across the U.S.
YouTube to start bringing back creators banned for misinformation
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
No Monologue, No Clicks: How Host Firings Disrupt Ad Revenue and Network Balance Sheets
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
What’s Next in Security: Wendi Whitmore’s Forecasts for 2025 Cyber Threats & Technologies
Wendi Whitmore, Chief Security Intelligence Officer at Palo Alto Networks, as she unpacks the top cybersecurity predictions.
Figure’s Nasdaq Debut Signals Strong Appetite for Real‑World Asset Finance
Figure CEO Michael Tannenbaum talks IPO raising ~$787.5M and share jump on debut, spotlighting surging demand in blockchain‑powered finance.
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
From Seedlings to Sustainability: Vita Coco Co-Founder on Eco‑Forward Path
Mike Kirban on how Vita Coco is shaping the future of beverages with sustainable sourcing, clean labeling and environmental impact tied to growth.
Mortgage Relief or Mirage? Where Rates Leave Homebuyers Today
Scott Trench, host of the BiggerPockets Money Podcast, explores how recent rate cuts, high borrowing costs, and mortgage rates are reshaping U.S. real estate.
